Immunological Mechanisms of Allergy Immunotherapy
NCT01914029 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 70
Last updated 2013-08-27
Summary
The purpose of the study is to add to the knowledge of mechanisms of immune health. Parameters of the immune system will be followed over time in volunteers allergic to dust mites and bee sting after receiving immunization therapy. This information will be compared to healthy volunteers without allergy. We aim to bring new understanding of immune processes by this comparison.
Conditions
- Allergy Desensitization
Sponsors & Collaborators
-
Rambam Health Care Campus
lead OTHER
Principal Investigators
-
Eduardo Shahar, Dr. · Rambam Health Care Campus
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-08-31
- Primary Completion
- 2014-07-31
- Completion
- 2016-07-31
Countries
- Israel
Study Locations
More Related Trials
-
Safety Study of Anti-IgE Immunotherapy in Allergic Patients
NCT00439621 ·Status: COMPLETED ·Phase: PHASE2
-
A Multicenter Study to Evaluate Safety and Efficacy of Specific Immunotherapy With Modified Allergen Extracts
NCT01012752 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy and Safety of Birch Pollen Immunotherapy in Local Allergic Rhinitis
NCT03157505 ·Status: COMPLETED ·Phase: PHASE3
-
Pilot Trial to Elaborate a Cutaneous Antigen Neutralization Test in Patients Suffering From Rhinoconjunctivitis
NCT00461721 ·Status: COMPLETED
-
House Dust Mite Injection Immunotherapy in Elderly Patients.
NCT03209245 ·Status: COMPLETED ·Phase: PHASE3
-
Allergen Immunotherapy in Allergic Patients
NCT02040974 ·Status: UNKNOWN
-
Immunotherapy Administered Under the Tongue to Treat Dust Mite Allergy
NCT00200850 ·Status: COMPLETED ·Phase: NA
-
Effects of Tregalizumab on Allergen-induced Airway Responses and Airway Inflammation in Asthmatic Patients
NCT04673591 ·Status: COMPLETED ·Phase: PHASE2
-
Determinism of the Mechanism of Action of Specific Immunotherapy in Hymenoptera Venom Allergy
NCT02295488 ·Status: COMPLETED ·Phase: NA
-
Mechanisms of Allergen Immunotherapy
NCT01523158 ·Status: TERMINATED ·Phase: NA
-
Radiofrequency Ablation of Bilateral Inferior Turbinate Followed by Subcutaneous Immunotherapy Trial
NCT05510024 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
ILIT: Follow-up of Rhinitis Quality of Life
NCT05037955 ·Status: COMPLETED
-
Effect of an Immunotoxin on Activated Human Macrophages in Those With Allergic Rhinitis or Mild Intermittent Asthma
NCT00295737 ·Status: TERMINATED ·Phase: NA
-
A Study of Ragweed (Ambrosia Artemisiifolia) Allergy Immunotherapy Tablet in Adults With Ragweed Allergies (P05751)
NCT01469182 ·Status: COMPLETED ·Phase: PHASE3
-
Noninterventional Study on Tolerability and Safety of One Strength Updosing With Novo-Helisen Depot House Dust Mites
NCT07096440 ·Status: NOT_YET_RECRUITING
-
Pilot Study of Allergy Immunotherapy and Prevention of Viral Respiratory Infections
NCT00405899 ·Status: COMPLETED
-
The Effect of Pollen Season on Subcutaneous Allergen Immunotherapy Reactions
NCT01878929 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Evaluation of Efficacy and Safety of Specific Immunotherapy With Modified Allergen Extracts of House Dust Mites
NCT01013116 ·Status: UNKNOWN ·Phase: PHASE3
-
Biomarker Screening for Immunotherapy Response Evaluation Using Microneedle Patch in Patients with Allergic Rhinitis
NCT05922176 ·Status: RECRUITING
-
A Motivation-enhancing App to Retain Patients With Hay Fever in a Trial After Treatment
NCT05560698 ·Status: COMPLETED ·Phase: NA
-
Clinical and Immunological Evaluation of Children With Allergies
NCT00102570 ·Status: COMPLETED
-
Evaluation of Immunological Changes and Clinical Efficacy of Specific Immunotherapy With Der p House Dust Mite Allergen in Polysensitized and Monosensitized Patients With Allergic Rhinitis and/or Asthma.
NCT01795846 ·Status: UNKNOWN
-
Safety and Efficacy Study of Intralymphatic Allergen-specific Immunotherapy
NCT02423707 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety and Efficacy of a Sublingual Specific Immunotherapy With an Extract of a Six Grass Pollen Mixture
NCT00264459 ·Status: COMPLETED ·Phase: PHASE3
-
Dose Finding Study for Depigoid Birch: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-Asthma
NCT01144429 ·Status: COMPLETED ·Phase: PHASE2